Our lab has expertise about ELISPOT analyses from the long peptide trial in end stage cervical carnoma, resected cervical carcinoma and VIN III patients.
created over 14 years ago(5 February 2010)last modified over 13 years ago(28 September 2011)
[ RDF ]
[ RelFinder ]
Sign in by typing your Id and password
Settings
Help
